| CXSS1800019 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | New Drug Application | 2018-09-06 | 勃林格殷格翰生物药业（中国）有限公司 | Boehringer Ingelheim Biopharmaceuticals (China) Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | Certificate Issued | 2020-01-06 | view |
| CYSB2300230 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2023-12-09 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CYSB2200110 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2022-04-27 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSB2200007 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2022-01-21 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSS2000014 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | New Drug Application | 2020-04-23 | 勃林格殷格翰生物药业（中国）有限公司 | Boehringer Ingelheim Biopharmaceuticals (China) Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | Certificate Issued | 2021-01-21 | view |
| CYSB2400335 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2025-01-01 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSB2200104 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2022-12-10 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSL2101060 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-05-11 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CYSB2000223 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2020-09-30 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd;BeiGene Guangzhou Biologics Manufacturing Co Ltd | In Review | 2020-09-30 | view |
| CYSB2101060 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-05-21 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSL2101005 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-03-18 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB1900020 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2019-08-28 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2019-08-27 | view |
| CYSB2400093 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2024-04-19 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSL2200060 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2022-01-29 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSL2101123 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-06-08 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSS2000032 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | New Drug Application | 2020-06-24 | 勃林格殷格翰生物药业（中国）有限公司 | Boehringer Ingelheim Biopharmaceuticals (China) Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-06-23 | view |
| CXSL2300042 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2023-01-17 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSL2101131 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-06-11 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSL2100051 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-02-09 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2021-02-08 | view |
| CXSB2000008 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2020-04-22 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-04-21 | view |
